Rentokil Initial plc [RTO] vs Copart [CPRT] Detailed Stock Comparison
Rentokil Initial plc
NYSE
Loading...
Copart
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Rentokil Initial plc wins in 4 metrics, Copart wins in 14 metrics, with 0 ties. Copart appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Rentokil Initial plc | Copart | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 37.65 | 30.14 | Copart |
| Price-to-Book Ratio | 11.35 | 5.01 | Copart |
| Debt-to-Equity Ratio | 115.51 | 1.15 | Copart |
| PEG Ratio | 40.90 | 26.16 | Copart |
| EV/EBITDA | 66.68 | 20.88 | Copart |
| Profit Margin (TTM) | 4.46% | 32.21% | Copart |
| Operating Margin (TTM) | 12.37% | 37.27% | Copart |
| EBITDA Margin (TTM) | 12.37% | 37.27% | Copart |
| Return on Equity | 5.13% | 18.44% | Copart |
| Return on Assets (TTM) | 3.24% | 12.02% | Copart |
| Free Cash Flow (TTM) | $463.00M | $961.57M | Copart |
| Dividend Yield | 2.50% | N/A | N/A |
| 1-Year Return | -22.18% | -12.02% | Copart |
| Price-to-Sales Ratio (TTM) | 2.16 | 9.59 | Rentokil Initial plc |
| Enterprise Value | $85.24B | $39.74B | Rentokil Initial plc |
| EV/Revenue Ratio | 11.60 | 8.66 | Copart |
| Gross Profit Margin (TTM) | N/A | 45.58% | N/A |
| Revenue per Share (TTM) | $11 | $5 | Rentokil Initial plc |
| Earnings per Share (Diluted) | $0.63 | $1.51 | Copart |
| Beta (Stock Volatility) | 0.35 | 1.07 | Rentokil Initial plc |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Rentokil Initial plc vs Copart Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Rentokil Initial plc | -4.24% | -5.20% | -2.31% | 3.63% | -3.18% | -5.46% |
| Copart | 0.40% | -2.53% | -8.32% | -24.78% | -21.21% | -19.19% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Rentokil Initial plc | -22.18% | -27.46% | -34.38% | 105.90% | 213.34% | 213.34% |
| Copart | -12.02% | 40.85% | 83.43% | 906.86% | 1,959.28% | 2,913.91% |
Performance & Financial Health Analysis: Rentokil Initial plc vs Copart
| Metric | RTO | CPRT |
|---|---|---|
| Market Information | ||
| Market Cap | $11.93B | $44.01B |
| Market Cap Category | Large cap | Large cap |
| 10 Day Avg. Volume | 1,107,170 | 5,940,840 |
| 90 Day Avg. Volume | 851,303 | 7,150,000 |
| Last Close | $23.72 | $45.51 |
| 52 Week Range | $19.60 - $34.07 | $45.05 - $64.38 |
| % from 52W High | -30.38% | -29.31% |
| All-Time High | $43.69 (Nov 08, 2021) | $64.38 (Nov 25, 2024) |
| % from All-Time High | -45.71% | -29.31% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.03% | 0.08% |
| Quarterly Earnings Growth | -0.24% | 0.06% |
| Financial Health | ||
| Profit Margin (TTM) | 0.04% | 0.32% |
| Operating Margin (TTM) | 0.12% | 0.37% |
| Return on Equity (TTM) | 0.05% | 0.18% |
| Debt to Equity (MRQ) | 115.51 | 1.15 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $2.09 | $9.08 |
| Cash per Share (MRQ) | $0.67 | $4.53 |
| Operating Cash Flow (TTM) | $1.00B | $1.80B |
| Levered Free Cash Flow (TTM) | $411.32M | $873.61M |
| Dividends | ||
| Last 12-Month Dividend Yield | 2.50% | N/A |
| Last 12-Month Dividend | $0.58 | N/A |
Valuation & Enterprise Metrics Analysis: Rentokil Initial plc vs Copart
| Metric | RTO | CPRT |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 37.65 | 30.14 |
| Forward P/E | 40.90 | 26.16 |
| PEG Ratio | 40.90 | 26.16 |
| Price to Sales (TTM) | 2.16 | 9.59 |
| Price to Book (MRQ) | 11.35 | 5.01 |
| Market Capitalization | ||
| Market Capitalization | $11.93B | $44.01B |
| Enterprise Value | $85.24B | $39.74B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 11.60 | 8.66 |
| Enterprise to EBITDA | 66.68 | 20.88 |
| Risk & Other Metrics | ||
| Beta | 0.35 | 1.07 |
| Book Value per Share (MRQ) | $2.09 | $9.08 |
Financial Statements Comparison: Rentokil Initial plc vs Copart
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | RTO | CPRT |
|---|---|---|
| Revenue/Sales | N/A | $1.21B |
| Cost of Goods Sold | N/A | $659.45M |
| Gross Profit | N/A | $552.27M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | N/A | $451.55M |
| EBITDA | N/A | $506.07M |
| Pre-Tax Income | N/A | $502.80M |
| Income Tax | N/A | $97.47M |
| Net Income (Profit) | N/A | $405.34M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | RTO | CPRT |
|---|---|---|
| Cash & Equivalents | $909.00M | $2.37B |
| Total Current Assets | $2.09B | $5.36B |
| Total Current Liabilities | $2.58B | $657.13M |
| Long-Term Debt | $2.81B | $81.27M |
| Total Shareholders Equity | $4.23B | $8.80B |
| Retained Earnings | $3.61B | $7.70B |
| Property, Plant & Equipment | $612.00M | $97.68M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | RTO | CPRT |
|---|---|---|
| Operating Cash Flow | N/A | $704.64M |
| Capital Expenditures | N/A | $-124.08M |
| Free Cash Flow | N/A | $572.92M |
| Debt Repayment | N/A | $-4,000 |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | RTO | CPRT |
|---|---|---|
| Shares Short | 2.10M | 28.63M |
| Short Ratio | 2.99 | 3.62 |
| Short % of Float | 0.00% | 0.04% |
| Average Daily Volume (10 Day) | 1,107,170 | 5,940,840 |
| Average Daily Volume (90 Day) | 851,303 | 7,150,000 |
| Shares Outstanding | 2.51B | 962.97M |
| Float Shares | 2.28B | 886.48M |
| % Held by Insiders | 0.00% | 0.09% |
| % Held by Institutions | 0.14% | 0.87% |
Dividend Analysis & Yield Comparison: Rentokil Initial plc vs Copart
| Metric | RTO | CPRT |
|---|---|---|
| Last 12-Month Dividend | $0.58 | N/A |
| Last 12-Month Dividend Yield | 2.50% | N/A |
| 3-Year Avg Annual Dividend | $0.53 | N/A |
| 3-Year Avg Dividend Yield | 0.88% | N/A |
| 3-Year Total Dividends | $1.58 | N/A |
| Ex-Dividend Date | Apr 04, 2025 | N/A |